AU2011265587B2 - Oleanoyl peptide composition and a method of treating skin aging - Google Patents

Oleanoyl peptide composition and a method of treating skin aging Download PDF

Info

Publication number
AU2011265587B2
AU2011265587B2 AU2011265587A AU2011265587A AU2011265587B2 AU 2011265587 B2 AU2011265587 B2 AU 2011265587B2 AU 2011265587 A AU2011265587 A AU 2011265587A AU 2011265587 A AU2011265587 A AU 2011265587A AU 2011265587 B2 AU2011265587 B2 AU 2011265587B2
Authority
AU
Australia
Prior art keywords
peptide
seq
linked
oleanolic acid
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2011265587A
Other languages
English (en)
Other versions
AU2011265587A1 (en
Inventor
Renukeshwar H. Chandramouli
Muhammed Majeed
Kalyanam Nagabhushanam
Subbalakshmi Prakash
Rattan SOOD
Susmitha Anand Tathapudi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sami Chemicals and Extracts Ltd
Original Assignee
Sami Chemicals and Extracts Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sami Chemicals and Extracts Ltd filed Critical Sami Chemicals and Extracts Ltd
Publication of AU2011265587A1 publication Critical patent/AU2011265587A1/en
Application granted granted Critical
Publication of AU2011265587B2 publication Critical patent/AU2011265587B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Emergency Medicine (AREA)
AU2011265587A 2010-12-28 2011-12-30 Oleanoyl peptide composition and a method of treating skin aging Ceased AU2011265587B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/979,667 2010-12-28
US12/979,667 US8987212B2 (en) 2007-08-07 2010-12-28 Oleanoyl peptide composition and method of treating skin aging

Publications (2)

Publication Number Publication Date
AU2011265587A1 AU2011265587A1 (en) 2012-07-12
AU2011265587B2 true AU2011265587B2 (en) 2017-01-05

Family

ID=45464381

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2011265587A Ceased AU2011265587B2 (en) 2010-12-28 2011-12-30 Oleanoyl peptide composition and a method of treating skin aging
AU2015381703A Ceased AU2015381703B2 (en) 2010-12-28 2015-12-22 Oleanoyl peptide composition and collagen enhancement

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2015381703A Ceased AU2015381703B2 (en) 2010-12-28 2015-12-22 Oleanoyl peptide composition and collagen enhancement

Country Status (10)

Country Link
US (3) US8987212B2 (https=)
EP (1) EP2510919A3 (https=)
JP (3) JP6176893B2 (https=)
KR (1) KR20170101946A (https=)
AU (2) AU2011265587B2 (https=)
BR (1) BRPI1105822A2 (https=)
CA (1) CA2975170C (https=)
EA (1) EA035128B9 (https=)
MY (1) MY188723A (https=)
WO (1) WO2012091743A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8987212B2 (en) * 2007-08-07 2015-03-24 Muhammed Majeed Oleanoyl peptide composition and method of treating skin aging
WO2016126343A1 (en) * 2015-02-05 2016-08-11 Muhammed Majeed Oleanoyl peptide composition and collagen enhancement
RU2709778C2 (ru) 2014-12-23 2019-12-20 Эйвон Продактс, Инк. Пептиды и их применение в уходе за кожей
US9597274B2 (en) * 2015-06-17 2017-03-21 Avon Products, Inc. Peptides and their use in the treatment of skin
US10493020B2 (en) 2016-04-14 2019-12-03 The Procter & Gamble Company Method of improving the appearance of periorbital dyschromia
KR102007078B1 (ko) 2017-03-24 2019-08-05 (주)셀아이콘랩 콜라겐 생성을 촉진시키는 신규한 헵타펩타이드 단량체 및 이량체를 포함하는 피부 노화 방지를 위한 화장품 조성물
RU2020113341A (ru) 2017-09-14 2021-10-15 Феникс Байотекнолоджи, Инк. Способ и композиция для лечения вирусной инфекции
KR20200083969A (ko) 2017-09-14 2020-07-09 피닉스 바이오테크놀러지 인코포레이티드. 신경학적 상태를 치료하기 위한 방법 및 개선된 신경보호 조성물
AU2018335280B2 (en) * 2017-09-21 2021-10-28 Sami Labs Limited Process for preparing tripeptide containing oleanolic acid and its therapeutic applications thereof
EA202092219A1 (ru) * 2018-04-03 2021-07-06 Сами Лабс Лимитед Композиции для ухода за кожей и их применение
CN110117307B (zh) * 2019-03-22 2020-08-04 中国医学科学院药用植物研究所 楤木皂苷衍生物及其制备方法和用途
CN110143994B (zh) * 2019-03-22 2020-08-04 中国医学科学院药用植物研究所 辽东楤木单体皂苷衍生物及其制备方法和用途
EP4009981B1 (en) 2020-03-31 2023-08-16 Phoenix Biotechnology, Inc. Method and compositions for treating coronavirus infection
JP7153083B2 (ja) 2020-03-31 2022-10-13 フェニックス・バイオテクノロジー・インコーポレイテッド コロナウイルス感染を治療するための方法および組成物
CZ308812B6 (cs) * 2020-04-09 2021-06-02 Contipro A.S. Pentapeptid odvozený od kaseinu a kompozice, která jej zahrnuje a jejich topické použit

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6124364A (en) * 1998-04-10 2000-09-26 Societe L'oreal S.A. Desquamation/epidermal renewal of the skin and/or combating skin aging
DE10121069A1 (de) * 2001-04-26 2002-10-31 Beiersdorf Ag Verwendung von Tetrahydrocurcuminoiden oder deren Derivaten als Wirkstoffe zur Herstellung von kosmetischen und dermatologischen Zubereitungen zum Schutz und zur Behandlung der trockenen bzw. alterstrockenen Haut
US20090169651A1 (en) * 2007-06-28 2009-07-02 Muhammed Majeed Anti-skin damage compositions with complimentary dual mode of action
US20100034758A1 (en) * 2007-08-07 2010-02-11 Muhammed Majeed Peptides Modified with Triterpenoids and Small Organic Molecules: Synthesis and use in Cosmeceuticals

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055298A (en) 1987-12-01 1991-10-08 Chemisches Laboratorium Dr. Kurt Richter Gmbh Cosmetic composition comprising an extracellular connective tissue matrix
US5198465A (en) 1991-06-19 1993-03-30 Dioguardi Francesco S Compositions based on amino acids for preventing and treating precursor deficiencies in the synthesis of collagen
EP1005333B1 (en) 1997-02-25 2005-01-12 The Regents Of The University Of Michigan Methods and compositions for preventing and treating chronological aging in human skin
US6809075B1 (en) 2000-05-30 2004-10-26 Connective Tissue Imagineering Llc Elastin peptide analogs and uses of same incombination with skin enhancing agents
FR2783169B1 (fr) * 1998-09-15 2001-11-02 Sederma Sa Utilisation cosmetique ou dermopharmaceutique de peptides pour la cicatrisation et pour l'amelioration de l'aspect cutane lors du vieillissement naturel ou accelere (heliodermie, pollution)
US6777389B1 (en) 1998-11-19 2004-08-17 Connective Tissue Imagineering Llc Cosmetic or dermatological use of 7-hydroxylated steroids in combination with elastin derived peptides
US6492326B1 (en) 1999-04-19 2002-12-10 The Procter & Gamble Company Skin care compositions containing combination of skin care actives
MXPA01013218A (es) * 1999-06-30 2002-06-04 Unilever Nv Composiciones cosmeticas para el cuidado de la piel conteniendo alcohol cumico.
US6794362B1 (en) 2000-05-30 2004-09-21 Connective Tissue Imagineering Llc Asparagine containing elastin peptide analogs
FR2813018B1 (fr) * 2000-08-21 2004-02-06 Boots Co Plc Compositions cosmetiques renfermant au moins un compose stimulant la neosynthese des laminines, et/ou de l'integrine alpha-2 beta-1 et/ou du collagene iv de la jonction dermo- epidermique
FR2826266B1 (fr) 2001-06-26 2005-02-25 Oreal Composition cosmetique ou dermatologique comprenant une association entre un compose de la famille des n-acylaminoamides et au moins un inhibiteur de metalloproteinases matricielles
US6906036B2 (en) 2001-08-16 2005-06-14 Kimberly-Clark Worldwide, Inc. Anti-aging and wound healing compounds
US20030124205A1 (en) * 2001-12-28 2003-07-03 Avon Products, Inc. Topical cosmetic composition having a natural plant active ingredient and method of using same
KR100753472B1 (ko) * 2002-03-15 2007-08-31 주식회사 엘지생활건강 사람 콜라겐 ⅰ형의 ｃ-말단에서 유래된 펩타이드에ｔａｔ 펩타이드가 결합된 융합 펩타이드, 이의 제조방법,및 이를 포함하는 피부주름개선 화장료 조성물
US8691247B2 (en) * 2006-12-26 2014-04-08 Ad Lunam Labs Inc. Skin rejuvenation cream
US8987212B2 (en) * 2007-08-07 2015-03-24 Muhammed Majeed Oleanoyl peptide composition and method of treating skin aging
US20110294731A1 (en) * 2009-02-13 2011-12-01 Invitrx, Inc. Skin cream

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6124364A (en) * 1998-04-10 2000-09-26 Societe L'oreal S.A. Desquamation/epidermal renewal of the skin and/or combating skin aging
DE10121069A1 (de) * 2001-04-26 2002-10-31 Beiersdorf Ag Verwendung von Tetrahydrocurcuminoiden oder deren Derivaten als Wirkstoffe zur Herstellung von kosmetischen und dermatologischen Zubereitungen zum Schutz und zur Behandlung der trockenen bzw. alterstrockenen Haut
US20090169651A1 (en) * 2007-06-28 2009-07-02 Muhammed Majeed Anti-skin damage compositions with complimentary dual mode of action
US20100034758A1 (en) * 2007-08-07 2010-02-11 Muhammed Majeed Peptides Modified with Triterpenoids and Small Organic Molecules: Synthesis and use in Cosmeceuticals

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Chaudhuri, R. K., et al. "Emblica cascading antioxidant: A novel natural skin care ingredient", Skin Pharmacol Appl Skin Physiol. 2002, vol. 15, pages 374-380. *

Also Published As

Publication number Publication date
EA035128B1 (ru) 2020-04-30
MY188723A (en) 2021-12-25
EP2510919A2 (en) 2012-10-17
EP2510919A3 (en) 2014-08-13
EA035128B9 (ru) 2020-08-07
JP6176893B2 (ja) 2017-08-09
CA2975170A1 (en) 2016-08-11
US8987212B2 (en) 2015-03-24
JP2018505890A (ja) 2018-03-01
JP2012140428A (ja) 2012-07-26
US10071043B2 (en) 2018-09-11
US20110091398A1 (en) 2011-04-21
BRPI1105822A2 (pt) 2018-11-21
AU2015381703B2 (en) 2020-02-20
AU2015381703A1 (en) 2017-07-27
AU2011265587A1 (en) 2012-07-12
US20150148297A1 (en) 2015-05-28
CA2975170C (en) 2020-04-14
WO2012091743A1 (en) 2012-07-05
KR20170101946A (ko) 2017-09-06
US20160113853A1 (en) 2016-04-28
JP2017206503A (ja) 2017-11-24
EA201791761A1 (ru) 2017-11-30

Similar Documents

Publication Publication Date Title
AU2011265587B2 (en) Oleanoyl peptide composition and a method of treating skin aging
US20140206842A1 (en) Peptides Modified with Triterpenoids and Small Organic Molecules: Synthesis and use in Cosmeceutical
US8025907B2 (en) Cosmetic composition to accelerate repair of functional wrinkles
Greatens et al. Effective inhibition of melanosome transfer to keratinocytes by lectins and niacinamide is reversible
US8383594B2 (en) Peptides modified with triterpenoids and small organic molecules: synthesis and use in cosmeceuticals
CA2713770C (en) Methods of treating skin with aromatic skin-active ingredients
US20140301961A1 (en) Compounds with anti-aging activities
US20080249073A1 (en) Skin Treatment Composition
KR101858095B1 (ko) 커큐민을 포함하는 강황 추출물을 유효 성분으로 포함하는 피부 미백, 주름 형성 억제, 및 소양증 완화용 화장품 조성물
JP2010006708A (ja) 皮膚外用剤、美白剤、抗老化剤および抗酸化剤
JP2013515704A (ja) アクアポリンの発現を活性化するための活性薬剤としてイナゴマメの抽出物を含む、化粧品組成物および／または医薬組成物
JP6282582B2 (ja) 皮膚老化の徴候を低減または遅延させるための、ジンゲロンまたはその誘導体の使用
EP3253400B1 (en) Oleanoyl peptide composition
KR100692951B1 (ko) 카텝신 비 저해물질을 유효성분으로 함유하는 기능성화장료 조성물
KR20060034471A (ko) 치자추출물을 유효성분으로 함유하는 기능성 화장료 조성물
WO2023209592A1 (en) Topical compositions containing vitamin c
BRPI0905308A2 (pt) composição clareadora cosmética e/ou dermatológica e formulação cosmética e/ou dermatológica contendo a mesma

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired